A detailed history of Brio Consultants, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Brio Consultants, LLC holds 2,602 shares of BIO stock, worth $720,597. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,602
Previous 2,602 -0.0%
Holding current value
$720,597
Previous $840,000 7.02%
% of portfolio
0.15%
Previous 0.15%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

BUY
$269.37 - $365.04 $700,900 - $949,834
2,602 New
2,602 $840,000
Q4 2021

Jan 19, 2022

SELL
$708.84 - $794.68 $265,815 - $298,005
-375 Closed
0 $0
Q3 2021

Oct 29, 2021

SELL
$657.71 - $825.77 $13,154 - $16,515
-20 Reduced 5.06%
375 $280,000
Q2 2021

Jul 22, 2021

SELL
$576.64 - $649.04 $5,189 - $5,841
-9 Reduced 2.23%
395 $254,000
Q1 2021

Apr 26, 2021

SELL
$547.01 - $662.35 $9,846 - $11,922
-18 Reduced 4.27%
404 $231,000
Q4 2020

Jan 11, 2021

BUY
$510.68 - $643.45 $215,506 - $271,535
422 New
422 $246,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.82B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Brio Consultants, LLC Portfolio

Follow Brio Consultants, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brio Consultants, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brio Consultants, LLC with notifications on news.